Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan
Tài liệu tham khảo
Abdel-Latif, 2015, Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia, Saudi Pharmaceut. J., 23, 154, 10.1016/j.jsps.2014.07.005
Abubakar, A. R., Simbak, N.B., Haque, M., 2014. A systematic review of knowledge, attitude and practice on adverse drug reactions and pharmacovigilance among doctors.
Adhikary, 2013, A study to assess knowledge, attitude and practice of adverse drug reaction reporting among physicians in a tertiary care hospital, J. Evol. Med. Dent. Sci., 2, 1027, 10.14260/jemds/374
Ahmad, 2013, An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study, Perspect. Clin. Res., 4, 204, 10.4103/2229-3485.120168
Ahsan, 2005, Pharmacy education and pharmacy council of Pakistan, Pakis. Drug Update, 6, 7
Alsaleh, 2016, Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait, Saudi Pharmaceut. J.
Anwar, M., Haq, N.U. Assessment of knowledge, attitude and practice of healthcare professional (pharmacist) regarding adverse drug reaction reporting and pharmacovigilance in public hospitals in Quetta, Pakistan.
Azhar, 2009, The role of pharmacists in developing countries: the current scenario in Pakistan, Hum. Resour. Health, 7, 54, 10.1186/1478-4491-7-54
Azhar, 2011, Perceptions of hospital pharmacist’s role in Pakistan’s healthcare system: a cross-sectional survey, Trop. J. Pharm. Res., 10, 10.4314/tjpr.v10i1.66535
Bateman, 1992, Attitudes to adverse drug reaction reporting in the Northern Region, Br. J. Clin. Pharmacol., 34, 421
Belton, 1995, Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br. J. Clin. Pharmacol., 39, 223, 10.1111/j.1365-2125.1995.tb04440.x
Bisht, 2014, Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study, ISRN Pharmacol., 10.1155/2014/259476
Canto, 2010
Desai, 2011, An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital, Perspect. Clin. Res., 2, 129, 10.4103/2229-3485.86883
Ekman, 2009, Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden, Eur. J. Clin. Pharmacol., 65, 43, 10.1007/s00228-008-0564-9
Figueiras, 2006, An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial, JAMA, 296, 1086, 10.1001/jama.296.9.1086
Ghaffar, 2000, Health care systems in transition III. Pakistan, part I. An overview of the health care system in Pakistan, J. Public Health Med., 22, 38, 10.1093/pubmed/22.1.38
Ghosh, 2010, Investigation of attitudes and perception of medical practitioners on adverse drug reaction reporting-a pilot study, T. Ph. Res., 3, 1
Gupta, 2011, Adverse drug reaction reporting and pharmacovigilance: knowledge, attitudes and perceptions amongst resident doctors, J. Pharm. Sci. Res., 3, 1064
Gupta, 2015, A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India, Perspect. Clin. Res., 6, 45, 10.4103/2229-3485.148816
Gurmesa, 2016
Gustafsson, 2011, The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm, Basic Clin. Pharmacol. Toxicol., 108, 224, 10.1111/j.1742-7843.2011.00682.x
Iffat, 2014, Pakistani physicians knowledge and attitude towards reporting adverse drug reactions, Afr. J. Pharm. Pharmacol., 8, 379
John, L.J., Arifulla, M., Cheriathu, J., Sreedharan, J., 2012. Reporting of adverse drug reactions: a study among cinicians.
Kamtane, 2012, Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: a pharmacoepidemiological study, Asian J. Pharm. Clin. Res., 5, 210
Khan, 2013, Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: an observational study, J. Natural Sci. Biol. Med., 4, 191, 10.4103/0976-9668.107289
Khan, 2006, From thalidomide to rofecoxib: Can we afford to wait and watch?, Int. J. Risk Saf. Med., 18, 219
Kumar, M.R., Bodhanapu, S., Mani, T.T., Phaneendra, P., Rahiman, O.F. Pharmacovigilance and its importance in drug regulation: an overview.
Lazarou, 1998, Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies, JAMA, 279, 1200, 10.1001/jama.279.15.1200
Lee, 1994, Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong, Ann. Pharmacother., 28, 1400, 10.1177/106002809402801213
Li, 2004, Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions, Chin. Med. J., 117, 856
Mahmood, 2011, Pharmacovigilance: a need for best patient care in Pakistan: a review, J. Pharm. Sci. Res., 3, 1566
McBride, 1961, Thalidomide and congenital abnormalities, The Lancet, 278, 1358, 10.1016/S0140-6736(61)90927-8
Mulatu, 2014, Assessment of knowledge, attitude and practice of health professionals towards adverse drug reaction reporting and factors associated with reporting, J. Pharmacovigil.
Nazir, 2014, Adverse drug reaction reporting system at different hospitals of Lahore – an evaluation and patient outcome analysis, Value Health, 17, A166, 10.1016/j.jval.2014.03.966
Oshikoya, 2009, Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria, BMC Clin. Pharmacol., 9, 14, 10.1186/1472-6904-9-14
Owusu-Daaku, 2008, Addressing the workforce crisis: the professional aspirations of pharmacy students in Ghana, Pharm. World Sci., 30, 577, 10.1007/s11096-008-9214-7
Palaian, 2011, Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal, Pharm. Pract., 9, 228, 10.4321/S1886-36552011000400008
Passier, 2009, Reporting of adverse drug reactions by general practitioners, Drug Saf., 32, 851, 10.2165/11314490-000000000-00000
Rajesh, 2011, An educational intervention to assess knowledge attitude practice of pharmacovigilance among health care professionals in an Indian tertiary care teaching hospital, Int. J. Pharm. Tech. Res., 3, 678
Ramachandudu, 2015, Importance of pharmacovigilance, Int. J. Emerg. Trends Sci. Technol., 2
Ramesh, 2003, Adverse drug reactions in a south Indian hospital—their severity and cost involved, Pharmacoepidemiol. Drug Saf., 12, 687, 10.1002/pds.871
Ramesh, 2009, Adverse drug reactions reporting: attitudes and perceptions of medical practitioners, Asian J. Pharm. Clin. Res., 2, 10
Raza, 2015, Assessment of knowledge, attitudes and practice among the medical and pharmacy students towards pharmacovigilance and adverse drug reactions in Abbottabad, Pakistan, J. Pharmacovigil.
Rishi, 2012, Opinion of physicians towards adverse drug reactions reporting results of pilot study, J. Commun. Nutrit. Health
Scott, 1990, Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project, JAMA, 263, 1785, 10.1001/jama.1990.03440130073028
Shah, 2016, A survey on knowledge, practice and perception of physicians and pharmacists on adverse drug reaction reporting – a pilot study, J. Pharm. Sci. Biosci. Res., 6, 483
Shakeel, 2014, Emerging need of pharmacovigilance: perspectives of future pharmacist in Pakistan, Int. J. Pharm. Teach. Pract., 5, 966
Shamim, 2016, Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists, SpringerPlus, 5, 1778, 10.1186/s40064-016-3337-4
Su, 2010, Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China, Pharmacoepidemiol. Drug Saf., 19, 217, 10.1002/pds.1792
Taneja, 2011, WHO international drug surveillance programme, Int. J. Pharm. Life Sci., 2
Toklu, 2016, The knowledge and attitude of the healthcare professionals towards pharmacovigilance and adverse drug reaction reporting in Northern Cyprus, J. Pharmacovigil., 10.4172/2329-6887.1000193
Upadhyaya, 2012, Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical college, Therapeut. Clin. Risk Manage., 8, 307, 10.2147/TCRM.S31482
WHO, 2010. Pharmaceutical Country Profile for Pakistan.
Wysowski, 2005, Adverse drug event surveillance and drug withdrawals in the United States, 1969–2002: the importance of reporting suspected reactions, Arch. Internal Med., 165, 1363, 10.1001/archinte.165.12.1363